GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » Debt-to-Revenue

Arix Bioscience (LSE:ARIX) Debt-to-Revenue : 0.69 (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Arix Bioscience's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.04 Mil. Arix Bioscience's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Arix Bioscience's annualized Revenue for the quarter that ended in Jun. 2023 was £0.05 Mil. Arix Bioscience's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.69.


Arix Bioscience Debt-to-Revenue Historical Data

The historical data trend for Arix Bioscience's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience Debt-to-Revenue Chart

Arix Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
Get a 7-Day Free Trial - 1.89 0.56 0.36 0.63

Arix Bioscience Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.39 0.76 0.70 0.69

Competitive Comparison of Arix Bioscience's Debt-to-Revenue

For the Biotechnology subindustry, Arix Bioscience's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arix Bioscience's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arix Bioscience's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Arix Bioscience's Debt-to-Revenue falls into.



Arix Bioscience Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Arix Bioscience's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.059 + 0.011) / 0.112
=0.63

Arix Bioscience's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.037 + 0) / 0.054
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.


Arix Bioscience Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Arix Bioscience (LSE:ARIX) Business Description

Traded in Other Exchanges
N/A
Address
50 Duke Street, Duke Street House, London, GBR, W1K 6JL
Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines